Calixar aims to become a leader in early drug discovery segment through unique technology and pipeline of novel and high-quality therapeutic targets Funds will enable company to isolate around 100 priority targets for the pharmaceutical industry.
Calixar aims to become a leader in early drug discovery segment through unique technology and pipeline of novel and high-quality therapeutic targets Funds will enable company to isolate around 100 priority targets for the pharmaceutical industry.
Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.